---
title: "GoodRx Holdings, Inc. (GDRX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GDRX.US.md"
symbol: "GDRX.US"
name: "GoodRx Holdings, Inc."
industry: "Health Care Technology"
datetime: "2026-05-19T09:49:02.905Z"
locales:
  - [en](https://longbridge.com/en/quote/GDRX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GDRX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GDRX.US.md)
---

# GoodRx Holdings, Inc. (GDRX.US)

## Company Overview

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets.

| Item | Detail |
|------|--------|
| Industry | Health Care Technology |
| Exchange | US Market |
| Website | [www.goodrx.com](https://www.goodrx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:12.000Z

**Overall: C (0.53)**

**Industry**: Health Care Technology

| Metric | Value |
|--------|-------|
| Industry Ranking | 16 / 47 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -1.19% |  |
| Net Profit YoY | -27.75% |  |
| P/B Ratio | 1.36 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 846688432.50 |  |
| Revenue | 787889000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.22% | C |
| Profit Margin | 2.61% | C |
| Gross Margin | 89.61% | A |
| Revenue YoY | -1.19% | D |
| Net Profit YoY | -27.75% | D |
| Total Assets YoY | 56.05% | A |
| Net Assets YoY | -4.95% | D |
| Cash Flow Margin | 828.61% | A |
| OCF YoY | -1.19% | D |
| Turnover | 0.48 | C |
| Gearing Ratio | 69.23% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - GoodRx Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-1.19%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-27.75%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.36",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "846688432.50",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "787889000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.22%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "2.61%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "89.61%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-1.19%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-27.75%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "56.05%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "-4.95%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "828.61%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-1.19%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.48",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "69.23%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 41.19 | 8/47 | 51.51 | 33.24 | 25.77 |
| PB | 1.36 | 17/47 | 2.43 | 1.64 | 1.31 |
| PS (TTM) | 1.07 | 14/47 | 1.95 | 1.26 | 0.99 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | QHSLab, Inc. (USAQ.US) | A | A | A | A | C | A |
| 02 | Veeva Systems -CL (VEEV.US) | A | B | C | A | B | B |
| 03 | Doximity (DOCS.US) | A | C | C | A | B | B |
| 04 | Waystar (WAY.US) | B | A | D | B | B | B |
| 05 | HeartFlow (HTFL.US) | B | A | B | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-16T04:00:00.000Z

Total Analysts: **15**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 27% |
| Overweight | 1 | 7% |
| Hold | 8 | 53% |
| Underweight | 2 | 13% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.50 |
| Highest Target | 3.50 |
| Lowest Target | 1.90 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/GDRX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/GDRX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/GDRX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/GDRX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**